Physician

Peter Rhee, MD

According to 2025 Medicare claims, Peter Rhee, MD (NPI: 1730280421) practices ophthalmology in the Waterloo-Cedar Falls, IA market, with the plurality of this provider's patient population coming from Black Hawk, IA. This provider's primary affiliated billing organization is WOLFE CLINIC INC (NPI: 1477532174; TIN: 420954581) and primary practice location at 50613-2380.

Rhee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,839 traditional Medicare patients, billed 8,567 HCPCS/CPT codes, and received $1,168,614 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,930 prescription claims across 578 beneficiaries totaling $293,738 in drug costs, led by Restasis (Cyclosporine). DME data shows 129 claims. Open Payments data shows 1 records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,437	10,326	$1,576,734
2016	2,309	9,628	$1,561,425
2017	2,287	9,532	$1,641,239
2018	2,232	9,624	$1,703,740
2019	2,165	9,153	$1,558,439
2020	1,767	7,365	$1,270,581
2021	2,045	8,633	$1,453,485
2022	2,009	8,072	$1,213,447
2023	1,958	8,154	$1,144,499
2024	1,839	8,567	$1,168,614

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	778	3,095	$367,246
2016	764	3,096	$384,010
2017	908	3,477	$403,253
2018	917	3,667	$396,422
2019	903	3,498	$391,522
2020	747	2,991	$410,028
2021	958	3,480	$458,443
2022	1,038	3,646	$484,467
2023	669	2,321	$369,667
2024	578	1,930	$293,738

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	110	111	$6,506
2016	140	140	$8,838
2017	89	89	$5,528
2018	149	153	$9,095
2019	63	66	$4,002
2020	61	63	$4,355
2021	70	73	$4,926
2022	96	103	$7,104
2023	112	134	$9,988
2024	125	129	$10,805

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	397	487	$82
92014	Established patient complete exam of visual system	464	465	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	573	661	$55
92134	Imaging of retina	602	1,044	$27
92136	Measurement of corneal curvature and depth of eye	373	1,055	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	125	4,530	$92,419
Lumigan	Bimatoprost	183	8,718	$80,514
Combigan	Brimonidine Tartrate/Timolol	34	2,016	$16,354
Xiidra	Lifitegrast	22	720	$16,340
Cyclosporine	Cyclosporine	36	1,275	$11,839

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	41	42	$4,507
V2020	Frames, purchases	N	62	63	$3,541
V2300	Sphere, trifocal, plano to plus or minus 4.00d, per lens	N	22	24	$2,757

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$28,214	US Retina LLC

Explore More Providers

FAQ

What Medicare data is available for Peter Rhee, MD?

Tedicare shows public-source Medicare data for Peter Rhee, MD (NPI 1730280421), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter Rhee, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter Rhee, MD?

Peter Rhee, MD is linked to WOLFE CLINIC INC (billing NPI 1477532174) in the available physician profile data.

Does Peter Rhee, MD have Open Payments data?

Peter Rhee, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.